A novel resorption assay for osteoclast functionality based on an osteoblast-derived native extracellular matrix.

Anne-Helen Lutter1, Ute Hempel, Cornelia Wolf-Brandstetter

  • 1Medical Faculty Carl Gustav Carus, Institute of Physiological Chemistry, Dresden University of Technology, Fiedlerstrasse 42, 01307 Dresden, Germany. ute.hempel@tu-dresden.de

Summary

A new assay uses decellularized osteoblast matrix to quantify osteoclast bone resorption. This method accurately measures osteoclast activity and inhibition, advancing bone disease research.